New Zealand - English - Medsafe (Medicines Safety Authority)

organon (new zealand) limited - enalapril maleate 5mg - tablet - 5 mg - active: enalapril maleate 5mg excipient: lactose monohydrate magnesium stearate maize starch sodium bicarbonate starch - treatment of: · all grades of essential hypertension

New Zealand - English - Medsafe (Medicines Safety Authority)

merck sharp & dohme (new zealand) limited - enalapril maleate 2.5mg;   - tablet - 2.5 mg - active: enalapril maleate 2.5mg   excipient: lactose monohydrate magnesium stearate maize starch sodium bicarbonate

Australia - English - Department of Health (Therapeutic Goods Administration)

organon pharma pty ltd - enalapril maleate, quantity: 5 mg - tablet, uncoated - excipient ingredients: sodium bicarbonate; magnesium stearate; lactose monohydrate; maize starch; pregelatinised maize starch - hypertension: renitec is indicated in the treatment of: - all grades of essential hypertension; - renovascular hypertension. congestive heart failure: renitec is indicated for the treatment of all degrees of symptomatic heart failure. in such patients, it is recommended that renitec be administered together with a diuretic. left ventricular dysfunction: all degrees of left ventricular dysfunction where the left ventricular ejection fraction is less than 35%, irrespective of the presence or severity of obvious symptoms of heart failure.

Australia - English - Department of Health (Therapeutic Goods Administration)

organon pharma pty ltd - hydrochlorothiazide, quantity: 6 mg; enalapril maleate, quantity: 20 mg - tablet, uncoated - excipient ingredients: indigo carmine; pregelatinised maize starch; magnesium stearate; sodium bicarbonate; lactose monohydrate; maize starch - renitec plus 20/6 is indicated for the treatment of mild to moderate hypertension. treatment should not be initiated with this fixed dose combination.

Australia - English - Department of Health (Therapeutic Goods Administration)

organon pharma pty ltd - enalapril maleate, quantity: 10 mg - tablet, uncoated - excipient ingredients: sodium bicarbonate; magnesium stearate; maize starch; iron oxide red; pregelatinised maize starch; lactose monohydrate - hypertension: renitec is indicated in the treatment of: - all grades of essential hypertension; - renovascular hypertension. congestive heart failure: renitec is indicated for the treatment of all degrees of symptomatic heart failure. in such patients, it is recommended that renitec be administered together with a diuretic. left ventricular dysfunction: all degrees of left ventricular dysfunction where the left ventricular ejection fraction is less than 35%, irrespective of the presence or severity of obvious symptoms of heart failure.

United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

city medical store - sole proprietorship l.l.c netherlands - 28 's (7's blister x 4) - tablet - 5mg / tablet - cardiovascular system-hypertension , heart failure

Singapore - English - HSA (Health Sciences Authority)

msd pharma (singapore) pte. ltd. - enalapril maleate - tablet - 5 mg/tablet

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - amiloride hydrochloride dihydrate, quantity: 5 mg - tablet, uncoated - excipient ingredients: maize starch; povidone; lactose monohydrate; microcrystalline cellulose; magnesium stearate - indications as at 15 july 1998 : kaluril's main indication is as concomitant therapy with diuretics to conserve potassium during periods of vigorous diuresis and during long-term maintenance therapy with thiazides or other more potent diuretics. kaluril when used alone, has mild diuretic and antihypertensive activity. oedema of cardiac origin. although kaluril alone may provide adequate diuresis for some patients with oedema of cardiac origin, it is primarily indicated for concomitant use in patients receiving thiazides or more potent saluretic diuretic agents. in these patients it may provide increased sodium, chloride and water excretion and decreased potassium excretion. the positive effect of kaluril on potassium balance may be especially important for digitalised cardiac patients, in whom potassium depletion sensitises or exaggerates the response of the heart to the toxic effects of digitalis (e.g. increased ventricular irritability), which may precipitate digitalis intoxication with potentially seriou

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

merck sharp & dohme b.v. - enalapril (enalapril maleate) - tablets - 5mg

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

merck sharp & dohme b.v. - enalapril (enalapril maleate) - tablets - 5mg